Epidemiology of quinolone resistance of Klebsiella pneumoniae and Klebsiella oxytoca in Europe

被引：37

作者：

Brisse, S

Milatovic, D

Fluit, AC

Verhoef, J

Schmitz, FJ

机构：

[1] Univ Utrecht, Eijkman Winkler Inst, NL-3584 CX Utrecht, Netherlands

[2] Univ Hosp Dusseldorf, Dept Med Microbiol & Virol, D-40225 Dusseldorf, Germany

来源：

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES | 2000年 / 19卷 / 01期

关键词：

D O I：

10.1007/s100960050014

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

The epidemiology of quinolone resistance and the concomitant resistance to other antibiotic classes was investigated in 445 Klebsiella pneumoniae and 238 Klebsiella oxytoca isolates. Decreased susceptibility to ciprofloxacin was found in 7.2% and 3.3% of these two species, respectively. Ciprofloxacin resistance was significantly linked to ceftazidime resistance, the hallmark of extended-spectrum beta-lactamase production, as well as to resistance to all antibiotic classes tested. Using automated ribotyping, seven intrahospital- and interhospital-transmitted clones of ciprofloxacin-resistant isolates were found. The newer fluoroquinolones sitafloxacin and clinafloxacin may become increasingly valuable, since they proved to be active also against ciprofloxacin-resistant isolates.

引用

收藏

页码：64 / 68

页数：5

相关论文

共 15 条

[1] HIGH-LEVEL QUINOLONE RESISTANCE AMONGST CLINICAL ISOLATES OF ESCHERICHIA-COLI AND KLEBSIELLA-PNEUMONIAE FROM SPAIN [J].

ALARCON, T ;

PITA, J ;

LOPEZBREA, M ;

PIDDOCK, LJV .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 32 (04) :605-609

[2] MULTICLONAL EMERGENCE OF CIPROFLOXACIN-RESISTANT CLINICAL ISOLATES OF ESCHERICHIA-COLI AND KLEBSIELLA-PNEUMONIAE [J].

BAUERNFEIND, A ;

ABELEHORN, M ;

EMMERLING, P ;

JUNGWIRTH, R .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 34 (06) :1074-1076

[3] Comparative in vitro activities of ciprofloxacin, clinafloxacin, gatifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter cloacae, and Enterobacter aerogenes clinical isolates with alterations in GyrA and ParC proteins [J].

Brisse, S ;

Milatovic, D ;

Fluit, AC ;

Verhoef, J ;

Martin, N ;

Scheuring, S ;

Köhrer, K ;

Schmitz, FJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (08) :2051-2055

[4]

DALHOFF A, 1994, INFECTION S2, V22, P111

[5] Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in quinolone-resistant clinical isolates of Klebsiella pneumoniae [J].

Deguchi, T ;

Fukuoka, A ;

Yasuda, M ;

Nakano, M ;

Ozeki, S ;

Kanematsu, E ;

Nishino, Y ;

Ishihara, S ;

Ban, Y ;

Kawada, Y .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (03) :699-701

[6] Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries [J].

Hanberger, H ;

Garcia-Rodriguez, JA ;

Gobernado, M ;

Goossens, H ;

Nilsson, LE ;

Struelens, MJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (01) :67-71

[7] Antibiotic resistance and production of extended-spectrum beta-lactamases amongst Klebsiella spp from intensive care units in Europe [J].

Livermore, DM ;

Yuan, M .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (03) :409-424

[8]

NCCLS - NATIONAL Committee for Clinical Laboratory Standards, 1997, M7A4 NCCLS

[9] RELATIONSHIP BETWEEN QUINOLONE USE AND EMERGENCE OF CIPROFLOXACIN-RESISTANT ESCHERICHIA-COLI IN BLOOD-STREAM INFECTIONS [J].

PENA, C ;

ALBAREDA, JM ;

PALLARES, R ;

PUJOL, M ;

TUBAU, F ;

ARIZA, J .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (02) :520-524

[10] Comparative evaluation of an automated ribotyping system versus pulsed-field gel electrophoresis for epidemiological typing of clinical isolates of Escherichia coli and Pseudomonas aeruginosa from patients with recurrent gram-negative bacteremia [J].

Pfaller, MA ;

Wendt, C ;

Hollis, RJ ;

Wenzel, RP ;

Fritschel, SJ ;

Neubauer, JJ ;

Herwaldt, LA .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1996, 25 (01) :1-8